| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |